GARY A LYONS Insider Trading $RIGL RIGEL PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY A LYONS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY A LYONS. GARY A LYONS is in Brickell Biotech, Inc. ($VICL) and Director in VICAL INC ($VICL) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CYTORI THERAPEUTICS, INC. ($XMP) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in Novus Therapeutics, Inc. ($TKAI) and Director in Retrophin, Inc. ($RTRX).
GARY A LYONS in RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2020
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GARY A LYONS in RIGEL PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, VICL, ELDN, KBIO, NBIX, PSTV, RIGL, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| May 24 2019 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 2.02 | 55,000 | 111,100 | 55,000 | |
| May 18 2018 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 3.98 | 40,000 | 159,200 | 40,000 | |
| May 12 2017 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 2.61 | 40,000 | 104,400 | 40,000 | |
| May 12 2016 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 2.40 | 40,000 | 96,000 | 40,000 | |
| May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | LYONS GARY A | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 |
Page: 1